CA2310290C - Composition et methode pour prevenir ou traiter le cancer du sein - Google Patents

Composition et methode pour prevenir ou traiter le cancer du sein Download PDF

Info

Publication number
CA2310290C
CA2310290C CA002310290A CA2310290A CA2310290C CA 2310290 C CA2310290 C CA 2310290C CA 002310290 A CA002310290 A CA 002310290A CA 2310290 A CA2310290 A CA 2310290A CA 2310290 C CA2310290 C CA 2310290C
Authority
CA
Canada
Prior art keywords
composition
isoflavone
serm
breast cancer
development
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002310290A
Other languages
English (en)
Other versions
CA2310290A1 (fr
Inventor
Richard B. Taylor
E. C. Henley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Archer Daniels Midland Co
Original Assignee
Solae LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solae LLC filed Critical Solae LLC
Priority to CA002310290A priority Critical patent/CA2310290C/fr
Publication of CA2310290A1 publication Critical patent/CA2310290A1/fr
Application granted granted Critical
Publication of CA2310290C publication Critical patent/CA2310290C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002310290A 2000-05-30 2000-05-30 Composition et methode pour prevenir ou traiter le cancer du sein Expired - Lifetime CA2310290C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002310290A CA2310290C (fr) 2000-05-30 2000-05-30 Composition et methode pour prevenir ou traiter le cancer du sein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002310290A CA2310290C (fr) 2000-05-30 2000-05-30 Composition et methode pour prevenir ou traiter le cancer du sein

Publications (2)

Publication Number Publication Date
CA2310290A1 CA2310290A1 (fr) 2001-11-30
CA2310290C true CA2310290C (fr) 2004-01-20

Family

ID=4166339

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002310290A Expired - Lifetime CA2310290C (fr) 2000-05-30 2000-05-30 Composition et methode pour prevenir ou traiter le cancer du sein

Country Status (1)

Country Link
CA (1) CA2310290C (fr)

Also Published As

Publication number Publication date
CA2310290A1 (fr) 2001-11-30

Similar Documents

Publication Publication Date Title
US6251400B1 (en) Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
US6326366B1 (en) Hormone replacement therapy
US8323706B2 (en) Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis
CA2325631A1 (fr) Therapie destinee aux troubles lies aux oestrogenes
US6300367B1 (en) Composition for and method of preventing or treating breast cancer
JP4286238B2 (ja) バクチオール含有薬剤組成物
JP4393062B2 (ja) ソホラ種からの抽出物、その製法およびその利用
ZA200305091B (en) Regulation of lipids and/or bone density and compositions therefor
EP1159963A1 (fr) Composition et procédé pour la prévention et le traitement du cancer du sein
JP3009599B2 (ja) フラボノイド配糖体を含む骨粗鬆症治療剤および骨粗鬆症治療用の可食性組成物
CA2310290C (fr) Composition et methode pour prevenir ou traiter le cancer du sein
KR20010108719A (ko) 유방암의 예방 또는 치료용 조성물 및 그 예방 또는 치료방법
AU4086900A (en) Composition for and method of preventing or treating breast cancer
CA2310294C (fr) Composition et methode pour prevenir ou traiter le cancer du sein
JP4286237B2 (ja) バクチオール含有薬剤組成物
KR100348147B1 (ko) 골다공증 예방 및 치료에 효과를 갖는 갈근 추출물
MXPA00006034A (en) Composition, prevention method or treatment for breast cancer
JP2001335484A (ja) 乳癌を予防又は治療するための組成物又はその方法
KR20090036803A (ko) 에스트로겐 활성이 우수한 보골지 추출물 또는 상기 보골지추출물로부터 분리한 활성성분을 포함하는 조성물
AU4879400A (en) Composition for and method of preventing or treating breast cancer
CN1335133A (zh) 预防或治疗乳腺癌的组合物和方法
JPH08165238A (ja) エストロゲン作用剤
JP2007507462A (ja) ホルモン補充療法における８−プレニルナリンゲニンの使用
MXPA00005292A (es) Composicion y metodo de prevencion o tratamiento de cancer de mama.
JP2001342132A (ja) 乳癌を予防し、もしくは治療するための組成物およびそのための方法

Legal Events

Date Code Title Description
EEER Examination request